Oncology
Smart technologies, integrated diagnosis and artificial intelligence can remove complexity and waste in oncology therapies. With the right information available at the right time, physicians are empowered in their decision-making and patients will benefit as a result.
These experts discuss the various ways in which technology, data and insights play a key role in advancing the quality of cancer care today and in the future.
With those MRIs, we can reduce the number of biopsies we are taking. We're saving 40% of biopsies. Not only is that a saving in monetary terms, it's also a saving of patient side effects." *
Christof Kastner, PhD, FRCS (Urol), FEBU
Consultant Urologist & Prostate Cancer Lead, Cambridge University Hospitals
Wouldn't it be a shame if a patient didn't know that a clinical trial was available? How do we make sure that their doctor knows about this particular trial? Wouldn't it be a shame if a physician wasn't aware of these particular steps that one had to take when starting on a specific complex medication regiment?"
David Jackman, M.D.
Medical Director of Clinical Pathways, Dana-Farber Cancer Institute
The precision of our equipment has allowed us to do things that are not necessarily available to most departments."
Lane Rosen, M.D.
Director of Radiation Oncology, Willis-Knighton Cancer Center
On the one hand we have what we want to describe as personalized medicine. So the treatment is tailored to what is found in the patient. And on the other hand, we want to more or less generalize how to use therapy in a group of patients."
Professor Pieter Postmus, M.D., PhD
Head of Department and Professor of Pulmonology, Leiden University Medical Centre
Share this article
Share this page
Find out how Philips can help you enable a clear care pathway with predictable outcomes for every patient.
*Results from case studies are not predictive of results in other cases. Results in other cases may vary.
You are about to visit a Philips global content page
ContinueThe information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).
By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.